This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07824/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07824/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07824/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07824/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07824/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07824
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07824 n12:DB07824
dcterms:title
4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one
adms:identifier
n8:DB07824 n9:GF4 n10:4465962 n13:5305969 n14:99444295
n5:IUPAC-Name
n6:271B42C9-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B42CF-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B42CE-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B42CB-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B42CC-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B42CD-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B42C7-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B42C8-363D-11E5-9242-09173F13E4C5 n6:271B42C5-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B42C6-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B42D5-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B42D6-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B42D0-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B42D1-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B42D3-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B42D2-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B42D4-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B42DB-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B42DD-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B42DE-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B42DA-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B42D9-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B42DC-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B42CA-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B42D7-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B42D8-363D-11E5-9242-09173F13E4C5